Adverse Drug Reaction News Bulletins
ADR News Bulletin 2023 September (Volume 25 Number 2)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
22 September 2023
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Reminder on the risk of pholcodine-associated perioperative anaphylaxis with neuromuscular blocking agents
Biotin interference with thyroid function tests
HSA is assessing the potential risk of suicidal thoughts and self-harm with glucagon-like peptide-1 receptor agonists (GLP-1 RA)
Reports of issues associated with the use of Cathejell (lignocaine 2% gel)
Click on the link below to download the issue in pdf: